ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,531Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 1024

$1.3M Total Retail Price of All Prescriptions

Rank: 23 out of 1024

808 Patients Receiving at Least One Drug in Part D
88% Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Connecticut
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

10% of this provider’s 808 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

4% of this provider’s 808 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
FUROSEMIDE 1,296 1,204 157 1 6
WARFARIN SODIUM 1,230 1,113 67 2 8
SIMVASTATIN 1,013 917 160 3 5
AMLODIPINE BESYLATE 926 852 140 4 3
LEVOTHYROXINE SODIUM 866 816 95 5 2
METOPROLOL TARTRATE 839 824 137 6 7
TRAZODONE HCL 825 752 132 7 22
LISINOPRIL 674 604 133 8 4
OMEPRAZOLE 646 578 149 9 9
ATORVASTATIN CALCIUM 637 577 114 10 1
MIRTAZAPINE 547 501 93 11 31
NAMENDA 431 363 34 12 27
GABAPENTIN 414 318 64 13 18
CYMBALTA 398 326 38 14 35
LORAZEPAM 386 331 81 B 15 26
DONEPEZIL HCL 354 354 47 16 25
POTASSIUM CHLORIDE 339 323 54 17 30
METFORMIN HCL 339 299 78 17 10
SERTRALINE HCL 338 276 47 19 23
ESCITALOPRAM OXALATE 335 302 58 20 14
RISPERIDONE 318 236 35 A 21 48
TAMSULOSIN HCL 294 289* 54 22 24
DIOVAN 291 286* 40 23 21
LANTUS 274 253 54 24 53
METOPROLOL SUCCINATE 256 227 52 25 12
OLANZAPINE 249 237 30 A 26 73
DIVALPROEX SODIUM 244 152 32 27 59
CARVEDILOL 243 221 42 28 40
ATENOLOL 240 235* 43 29 13
QUETIAPINE FUMARATE 237 196 37 A 30 44
CLOPIDOGREL 234 218 48 31 28
CITALOPRAM HBR 226 221* 36 32 37
HYDRALAZINE HCL 223 218* 32 33 91
TRAMADOL HCL 223 208 72 33 36
COLCRYS 202 197* 34 35 131
PREDNISONE 202 177 68 35 38
ZOLPIDEM TARTRATE 198 173 56 37 19
RANITIDINE HCL 197 192* 41 38 68
LEVETIRACETAM 188 139 23 39 75
CLONAZEPAM 164 109 23 B 40 57
RAMIPRIL 162 157* 24 41 86
LOSARTAN POTASSIUM 158 153* 35 42 16
HUMALOG 154 149* 38 43 123
IPRATROPIUM-ALBUTEROL 139 111 65 44 80
ALLOPURINOL 135 135 22 45 34
PRAVASTATIN SODIUM 135 118 34 45 15
PANTOPRAZOLE SODIUM 123 108 29 47 29
GLIMEPIRIDE 118 113* 25 48 54
CRESTOR 118 113* 25 48 20
HYDROCHLOROTHIAZIDE 118 96 34 48 11
CLOZAPINE 114 <11 <11 A 51 104
LAMOTRIGINE 106 <11 <11 52 125
CIPROFLOXACIN HCL 104 99* 86 53 78
ALPRAZOLAM 103 98* 29 B 54 17
OXYCODONE HCL 102 97* 29 S2 55 55
ACETAMINOPHEN-CODEINE 101 96* 29 S3 56 150
SULFAMETHOXAZOLE-TRIMETHOPRIM 100 95* 48 57 116
MELOXICAM 98 69 24 58 62
FINASTERIDE 97 97 21 59 76
DOXAZOSIN MESYLATE 97 97 21 59 90
OXYCODONE-ACETAMINOPHEN 93 61 30 S2 61 61
ISOSORBIDE MONONITRATE ER 91 86* 17 62 63
LATANOPROST 90 90 16 63 156
DIGOX 88 73 21 64 81
ADVAIR DISKUS 87 62 24 65 41
POLYETHYLENE GLYCOL 3350 87 75 46 65 97
GLIPIZIDE 85 85 19 67 66
AZITHROMYCIN 84 79* 73 68 50
NOVOLOG FLEXPEN 80 66 14 69 144
SPIRIVA 80 65 18 69 47
NEXIUM 79 51 11 71 33
CARBIDOPA-LEVODOPA 79 79 13 71 92
PAROXETINE HCL 79 74* 15 71 72
FENTANYL 79 74* 14 S2 71 99
OXYBUTYNIN CHLORIDE ER 77 72* 11 75 93
ROPINIROLE HCL 77 <11 <11 75 132
LIDODERM 76 62 22 77 69
CARBAMAZEPINE 76 <11 <11 77 139
CEPHALEXIN 75 70* 48 79 146
VENLAFAXINE HCL ER 74 <11 <11 80 103
TRIAMCINOLONE ACETONIDE 74 69* 25 80 145
NOVOLOG 74 69* 22 80 101
SPIRONOLACTONE 74 74 11 80 71
HYDROMORPHONE HCL* 73 53 12 S2 84 165
ZETIA 73 <11 <11 84 52
TIZANIDINE HCL 72 <11 <11 86 178
CLOZAPINE ODT 72 <11 <11 A 86 272
ALENDRONATE SODIUM 72 72 18 86 39
DILTIAZEM HCL 71 71 13 89 250
LACTULOSE 69 64* 22 90 105
BUDESONIDE 69 48 12 90 236
DILTIAZEM 24HR CD 69 64* 15 90 110
TOPIRAMATE 64 <11 <11 93 160
CLOTRIMAZOLE-BETAMETHASONE 63 46 30 94 121
DEXTROSE WITH SODIUM CHLORIDE 63 58* 30 94 295
METOLAZONE 63 58* 12 94 199
OXCARBAZEPINE 63 <11 <11 94 191
AMOX TR-POTASSIUM CLAVULANATE 62 57* 55 98 111
TRADJENTA 62 <11 <11 98 251
PIOGLITAZONE HCL 61 56* 12 R 100 67
KLOR-CON M20 60 55* 12 101 70
BACLOFEN 59 54* 11 102 98
DILTIAZEM 24HR ER 59 54* 16 102 108
GLUCAGEN 57 52* 22 104 320
LEVEMIR 57 52* 14 104 169
MONTELUKAST SODIUM 56 51* 15 106 46
NAPROXEN 55 43 17 107 119
LEVOFLOXACIN 55 44 47 107 94
HALOPERIDOL 54 <11 <11 A 109 141
FAMOTIDINE* 54 49* 14 109 106
LYRICA 54 <11 <11 109 100
ABILIFY 53 <11 <11 A 112 77
HYDROCORTISONE 52 47* 27 113 239
FLUOXETINE HCL 52 <11 <11 113 88
NOVOLIN R 52 47* 17 113 175
LANTUS SOLOSTAR 51 33 13 116 82
JANUVIA 51 51 12 116 45
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 10, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.